MR
Max Rosett (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Immunome, Inc. (IMNM). The largest single filing was $1.4M of IMNM (63,656 sh × $21.91, as filed), executed Apr 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Jun 15
Filed Jun 17
Median ADV $31.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
IMNMRecent filings
IMNMSALE
Immunome, Inc.
View filing →
$1.1M60,000 sh × $18.23
Exec Jun 15
Filed Jun 17 · 5:30 PM ET IMNMSALE Immunome, Inc. View filing → $1.4M
63,656 sh × $21.91
Exec Apr 2
Filed Apr 3 · 5:30 PM ET